Cargando…
Proteomic profiling of high risk medulloblastoma reveals functional biology
Genomic characterization of medulloblastoma has improved molecular risk classification but struggles to define functional biological processes, particularly for the most aggressive subgroups. We present here a novel proteomic approach to this problem using a reference library of stable isotope label...
Autores principales: | Staal, Jerome A., Lau, Ling San, Zhang, Huizhen, Ingram, Wendy J., Hallahan, Andrew R., Northcott, Paul A., Pfister, Stefan M., Wechsler-Reya, Robert J., Rusert, Jessica M., Taylor, Michael D., Cho, Yoon-Jae, Packer, Roger J., Brown, Kristy J., Rood, Brian R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546489/ https://www.ncbi.nlm.nih.gov/pubmed/25970789 |
Ejemplares similares
-
Proteomic analysis of Medulloblastoma reveals functional biology with translational potential
por: Rivero-Hinojosa, Samuel, et al.
Publicado: (2018) -
Depletion of kinesin motor KIF20A to target cell fate control suppresses medulloblastoma tumour growth
por: Qiu, Runxiang, et al.
Publicado: (2021) -
Subgroup-Enriched
Pathways and Kinase Signatures in
Medulloblastoma Patient-Derived Xenografts
por: Leskoske, Kristin L., et al.
Publicado: (2022) -
Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
por: Lee, Catherine, et al.
Publicado: (2019) -
OMIC-05. PHOSPHOPROTEOMIC ANALYSIS IDENTIFIES SUBGROUP ENRICHED PATHWAYS AND KINASE SIGNATURES IN MEDULLOBLASTOMA
por: Leskoske, Kristin, et al.
Publicado: (2021)